Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Novel ryanodine receptor 2 mutation associated with a severe phenotype of catecholaminergic polymorphic ventricular tachycardia.

LaPage MJ, Russell MW, Bradley DJ, Dick M 2nd.

J Pediatr. 2012 Aug;161(2):362-4. doi: 10.1016/j.jpeds.2012.04.013. Epub 2012 May 19.

PMID:
22608700
2.

A de novo novel cardiac ryanodine mutation (Ser4155Tyr) associated with catecholaminergic polymorphic ventricular tachycardia.

Mantziari L, Vassilikos V, Anastasakis A, Kotsaka X, Paraskevaidis S, Styliadis IH, Luria D.

Ann Noninvasive Electrocardiol. 2013 Nov;18(6):571-6. doi: 10.1111/anec.12089. Epub 2013 Oct 23.

PMID:
24147812
3.

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA.

Circulation. 2001 Jan 16;103(2):196-200.

4.

Catecholaminergic polymorphic ventricular tachycardia caused by a novel mutation in the cardiac ryanodine receptor.

Hasdemir C, Aydin HH, Sahin S, Wollnik B.

Anadolu Kardiyol Derg. 2008 Oct 16;8(5):E35-6. No abstract available.

5.

A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia.

Hsueh CH, Weng YC, Chen CY, Lin TK, Lin YH, Lai LP, Lin JL.

Int J Cardiol. 2006 Apr 4;108(2):276-8.

PMID:
16517285
6.
7.

Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.

Diffley M, Armenian P, Gerona R, Reinhartz O, Avasarala K.

Crit Care Med. 2012 Jul;40(7):2223-6. doi: 10.1097/CCM.0b013e318250a870.

PMID:
22584762
8.

Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro.

Marjamaa A, Laitinen-Forsblom P, Wronska A, Toivonen L, Kontula K, Swan H.

Int J Cardiol. 2011 Mar 3;147(2):246-52. doi: 10.1016/j.ijcard.2009.08.041. Epub 2009 Sep 25.

PMID:
19781797
9.

Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.

Marjamaa A, Laitinen-Forsblom P, Lahtinen AM, Viitasalo M, Toivonen L, Kontula K, Swan H.

BMC Med Genet. 2009 Feb 12;10:12. doi: 10.1186/1471-2350-10-12.

10.

S4153R is a gain-of-function mutation in the cardiac Ca(2+) release channel ryanodine receptor associated with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.

Zhabyeyev P, Hiess F, Wang R, Liu Y, Wayne Chen SR, Oudit GY.

Can J Cardiol. 2013 Aug;29(8):993-6. doi: 10.1016/j.cjca.2012.12.019. Epub 2013 Mar 13.

PMID:
23498838
11.

A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by β-blocker therapy.

Kazemian P, Gollob MH, Pantano A, Oudit GY.

Can J Cardiol. 2011 Nov-Dec;27(6):870.e7-10. doi: 10.1016/j.cjca.2011.02.003. Epub 2011 Jun 8.

PMID:
21652165
12.
13.

A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.

Aizawa Y, Ueda K, Komura S, Washizuka T, Chinushi M, Inagaki N, Matsumoto Y, Hayashi T, Takahashi M, Nakano N, Yasunami M, Kimura A, Hiraoka M, Aizawa Y.

Int J Cardiol. 2005 Mar 18;99(2):343-5.

PMID:
15749201
14.

Catecholaminergic polymorphic ventricular tachycardia.

Leenhardt A, Denjoy I, Guicheney P.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1044-52. doi: 10.1161/CIRCEP.111.962027. Epub 2012 Sep 27. Review. No abstract available.

15.
16.

A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.

Arakawa J, Hamabe A, Aiba T, Nagai T, Yoshida M, Touya T, Ishigami N, Hisadome H, Katsushika S, Tabata H, Miyamoto Y, Shimizu W.

Heart Vessels. 2015 Nov;30(6):835-40. doi: 10.1007/s00380-014-0555-y. Epub 2014 Aug 5.

PMID:
25092222
17.

Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation.

Kaneshiro T, Naruse Y, Nogami A, Tada H, Yoshida K, Sekiguchi Y, Murakoshi N, Kato Y, Horigome H, Kawamura M, Horie M, Aonuma K.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):e14-7. doi: 10.1161/CIRCEP.111.966549. No abstract available.

18.

RYR2 and CASQ2 mutations in patients suffering from catecholaminergic polymorphic ventricular tachycardia.

Lahat H, Pras E, Eldar M.

Circulation. 2003 Jan 28;107(3):e29; author reply e29. No abstract available.

19.

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.

Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.

Europace. 2010 Mar;12(3):417-23. doi: 10.1093/europace/eup448. Epub 2010 Jan 26.

PMID:
20106799
20.

A classic electrocardiographic manifestation of catecholaminergic polymorphic ventricular tachycardia.

Richter S, Gebauer R, Hindricks G, Brugada P.

J Cardiovasc Electrophysiol. 2012 May;23(5):560. doi: 10.1111/j.1540-8167.2011.02138.x. Epub 2011 Aug 1. No abstract available.

PMID:
21806698

Supplemental Content

Support Center